Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 1, 2009Expert Opinion on Drug Delivery

Carbon nanotubes in drug delivery: focus on infectious diseases

View Full Paper
Ask AI
Bookmark
Share

Authors

YRYitzhak RosenNENoel M. Elman

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Rosen et al. (2009) studied this question.

synapsesocial.com/papers/6a89cb6181d3bfa98ef7de53https://doi.org/10.1517/17425240902865579
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Biomedical Applications and Potential Health Risks of Nanomaterials: Molecular Mechanisms2006 · 434 citations
  2. 2Antisense inhibition of the p65 subunit of NF-kappa B blocks tumorigenicity and causes tumor regression.1993 · 262 citations
  3. 3Epidemiology of Drug Resistance: Implications for a Post—Antimicrobial Era1992 · 1,315 citations
  4. 4Hepatitis C-Related Hepatocellular Carcinoma1993 · 64 citations
  5. 5Dispersion and Solubilization of Carbon Nanotubes2003 · 105 citations